INSPIRATION HEALTHCARE GROUP PLC

Report Publication Announcement • Sep 23, 2025

National Storage Mechanism | Additional information

RNS Number : 2860A

Inspiration Healthcare Group PLC

23 September 2025

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Results presentations for analysts and investors

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces it will host analyst and investor presentations on Tuesday, 7 October 2025, following the release of its interim results for the 6 months ended 31 July 2025.

Analyst briefing

Raffi Stepanian CEO, and Alan Olby CFO, will host a briefing to equity research analysts on Tuesday 7 October 2025 at 09.30am BST. To register and for more details please contact Walbrook PR on [email protected] .

Investor presentation

Management will also provide a live presentation relating to the results via the Investor Meet Company platform on Tuesday, 7 October 2025 at 11.00am BST.  

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation. Investors can sign up to Investor Meet Company for free and add to meet Inspiration Healthcare.

To register for the presentation, please do so here .  

Investors who already follow Inspiration Healthcare on the Investor Meet Company platform will automatically be invited.

For further information, please contact:

Inspiration Healthcare Group plc		Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer Alan Olby, Chief Financial Officer
Panmure Liberum (Nominated Adviser & Broker)			Tel: +44 (0)20 3100 2000
Will Goode Emma Earl Mark Rogers
Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or [email protected]
Anna Dunphy		Mob: +44 (0) 7876 741 001
Rachel Broad

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at  www.inspirationhealthcaregroup.com      

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCBDGDCIDDDGUD